Concepedia

Publication | Closed Access

Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT

DOI

11

Citations

20

References

2013

Year

Andrew J. Innes, R Mark Beattie, Ruhena Sergeant, Gandhi Damaj, Letizia Foroni, David Marín, Edward Kanfer, Stephan Mielke, Dragana Milojković, D. Macdonald,
Bone Marrow Transplantation

References

YearCitations

Page 1